GlassScriptPhysician profile
Anderson A Bauer
NPI 1043422207
$1,641.37
in general payments reported to CMS, 2019-2025
28 companies · $33.08 in 2025
The $33.08 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $262 · 2021: $550 · 2023: $35.57 · 2024: $17.28 · 2025: $33.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $85.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $85.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $500.00 | 2021 | |
| Astellas Pharma US INC | $118.16 | 2019-2020 | |
| Lilly USA, LLC | $117.27 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.19 | 2019 | |
| Varian Medical Systems, INC. | $78.52 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $60.19 | 2019-2020 | |
| Seagen INC. | $59.29 | 2019-2020 | |
| Abbvie INC. | $50.36 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $49.78 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $49.61 | 2019 | |
| Celgene Corporation | $46.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $45.22 | 2019-2020 | |
| Janssen Biotech, INC. | $43.59 | 2019 | |
| Amgen INC. | $39.27 | 2019 | |
| Pfizer INC. | $34.83 | 2019-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $34.39 | 2019-2020 | |
| Genzyme Corporation | $28.81 | 2019 | |
| Tactile Systems Technology INC | $22.94 | 2020 | |
| Rigel Pharmaceuticals, INC. | $22.93 | 2019 | |
| Boston Scientific Corporation | $20.56 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.25 | 2020 | |
| Merck Sharp & Dohme LLC | $18.22 | 2020 | |
| Mylan Institutional INC. | $18.18 | 2019 | |
| Qfix | $14.32 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $12.81 | 2023 | Epkinly, Imbruvica |
| Carbofix Orthopedics INC | $12.30 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $11.53 | 2020 | |
| Clovis Oncology, INC. | $9.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anderson Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.